Bay City Capital Fund V, L.P.
CIK 1401826 · last filed 2020-03-16
Bay City Capital Fund V, L.P. is a corporate insider who has filed 9 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing, for IMRA, was dated Mar 16, 2020. Across all open-market trades the lifetime net is −$39.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$11.75M
4
9
-$39.17M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMRA | 10%+ Owner | 690,232 | $17.02 | $11.75M | $0 | 1 | 2020-03-16 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | 10%+ Owner | 4,795,570 | $18.62 | $89.29M | -$9.60M | 1 | 2014-08-29 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 2,829,136 | $1.47 | $4.16M | -$28.11M | 2 | 2014-08-28 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | 10%+ Owner | 2,230,880 | — | — | -$1.46M | 5 | 2013-07-19 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-16 | IMRA | Mixed | +3,516,900 | $0 | EDGAR |
| 2014-08-29 | Viracta Therapeutics, Inc. (SNSS) Delisted | Sell (S) | −1,202,800 | -$9.60M | EDGAR |
| 2014-08-28 | Epizyme, Inc. (EPZM) Delisted | Sell (S) | −800,000 | -$28.11M | EDGAR |
| 2014-08-28 | Epizyme, Inc. (EPZM) Delisted | — | — | $0 | EDGAR |
| 2013-07-19 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Exer (X) | −46,800 | -$1.05M | EDGAR |
| 2013-07-19 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Exer (X) | −383,612 | -$9.99M | EDGAR |
| 2013-05-31 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Exer (X) | +45,104 | $211.6K | EDGAR |
| 2013-05-30 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Sell (S) | −69,464 | -$1.46M | EDGAR |
| 2012-08-02 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Mixed | +9,811,576 | $45.65M | EDGAR |